These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis. Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis. Ghanem RC; Vargas JF; Ghanem VC Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789 [TBL] [Abstract][Full Text] [Related]
7. Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis. Comstock TL; DeCory HH Ocul Immunol Inflamm; 2017 Apr; 25(2):267-274. PubMed ID: 26788833 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis. Jeng BH; Holsclaw DS Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis. Bhargava R; Kumar P Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215 [TBL] [Abstract][Full Text] [Related]
11. Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis. Alevi D; Barsam A; Kruh J; Prince J; Perry HD; Donnenfeld ED J Cataract Refract Surg; 2012 Jun; 38(6):1028-33. PubMed ID: 22624902 [TBL] [Abstract][Full Text] [Related]
12. Development of EKC after eximer laser photorefractive surgery and subsequent recurrence of EKC-like keratitis. Park SJ; Jang YS; Koh TH; Kwon YA; Song SW Korean J Ophthalmol; 2011 Dec; 25(6):443-6. PubMed ID: 22131783 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis. Aydin Kurna S; Altun A; Oflaz A; Karatay Arsan A Acta Ophthalmol; 2015 Jun; 93(4):377-82. PubMed ID: 25043311 [TBL] [Abstract][Full Text] [Related]
15. Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis. Rhee SS; Mah FS Adv Ther; 2007; 24(1):60-7. PubMed ID: 17526462 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery. Abessi B; Brooksby L; Schultze RL Eye Contact Lens; 2018 Nov; 44 Suppl 2():S37-S42. PubMed ID: 28628490 [TBL] [Abstract][Full Text] [Related]
17. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis. Ilyas H; Slonim CB; Braswell GR; Favetta JR; Schulman M Eye Contact Lens; 2004 Jan; 30(1):10-3. PubMed ID: 14722462 [TBL] [Abstract][Full Text] [Related]
18. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid. Comstock TL; Sheppard JD Expert Opin Pharmacother; 2018 Mar; 19(4):337-353. PubMed ID: 29430976 [TBL] [Abstract][Full Text] [Related]
19. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis. Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732 [TBL] [Abstract][Full Text] [Related]
20. [Epidemic keratoconjunctivitis: treatment results during an epidemic]. Hutter H Klin Monbl Augenheilkd; 1990 Sep; 197(3):214-7. PubMed ID: 1701507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]